Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus

Author:

Aleman Soo12,Söderholm Jonas34ORCID,Büsch Katharina34,Kövamees Jan3,Duberg Ann‐Sofi5ORCID

Affiliation:

1. Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

2. Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden

3. AbbVie AB Stockholm Sweden

4. Division of Clinical Microbiology Department of Laboratory Medicine Karolinska Institutet at Karolinska University Hospital Huddinge Stockholm Sweden

5. Department of Infectious Diseases Faculty of Medicine and Health Örebro University Örebro Sweden

Funder

AbbVie

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection

3. World Health Organization.Global hepatitis report 2017.http://www.who.int/hepatitis/publications/global‐hepatitis‐report2017/en/. Accessed May 24 2019.

4. World Health Organization.Combating hepatitis B and C to reach elimination by 2030.http://apps.who.int/iris/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.pdf?sequence=1. Accessed June 19 2017.

5. Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3